Consistent with the immunophenotypic findings, AML patients displayed overexpression of senescent-related genes, including B3GAT1 (encoding CD57) and KLRG1, as well as inhibitory receptors, including CD160, CD244 (which encodes 2B4), LAG3 and TIGIT. This evidence concerns the gene B3GAT1 and acute myeloid leukemia.